Subscribe To Our Free Newsletter |
Mankind Pharma shares in focus as company approves Rs 10,000 crore fundraise plan
The company's board of directors on Monday approved raising up to Rs 5,000 crore via non-convertible debentures in 3-4 distinct series with maturities of up to 48 months, in a regulatory filing to stock exchanges.